본문 바로가기 주메뉴 바로가기

제품소개

제품상세페이지

Virongy

[Virongy] SARS-CoV-2 Pseudoviral Neutralization Assay Kit

Cat-No.


Virongy는 혁신적인 바이러스 연구 및 진단 기술을 개발하는 미국의 바이오기업으로,

바이러스 감염 연구와 치료법 개발을 위한 선도적인 솔루션을 제공합니다.







제품 설명 


SARS-CoV-2 Pseudoviral Neutralization Assay Kit

 



제품 번호


제품 분류:

Choose an optionAdd-Ons

Wild Type

D614G Single Mutation

AY4/BA.1 "Deltacron"

Alpha (B.1.1.7)

B.1.1.207

B.1.1.298

B.1.2

B.1.258

B.1.494

BA.2

BA.2.12.1

BA.4 and BA.5

BA.4.6

BA.2.75

Beta (B.1.351)

BQ.1

BQ.1.1

CH.1.1

Delta (B.1.617.2)

Delta Plus (AY.2)

Delta Plus (AY4.2)

DV.7.1.2

EG.10.1

Epsilon (B.1.427/429)

Epsilon (B.1.429)

Eta (B.1.525)

FL.1.5.1

FL.10.1

GK.1.1

Gamma (P.1)

GW.5.1.1

HF.1

HK.3

HV.1

HW.1.1

JB.2.1

JD.1.1

JF.1

JH.2

JH.2

JN.1

JP.1

Kappa (B.1.617.1)

Lambda (C.37)

Mu (B.1.621)

Omicron (B.1.1.529)

XBB.1

XBB.1.5

XBB.1.9.1

XBB.1.16

XBB.1.16.11

XBB.1.41.1

XBB.2.3

50 µL of Standard Neutralizing Antibody 

1 Tube of Ready-To-Use Target Cells (5 Million Cells/Tube)

15 mL of VBI Infection Medium





제품 특징


Kit Includes:

  • 5 mL of Pseudovirus Particles
  • 1 Tube of Ready-To-Use Target Cells (5 Million Cells/Tube)
  • 15 mL of VBI Infection Medium
  • 2 mL of Lysis Buffer
  • 3.5 mL of Firefly Luciferase Assay Buffer

Kit Does Not Include Standard Neutralizing Antibody – Available as an Add-On


Pseudoviral Neutralization Assay Kit

Utilizing Our NEW Hybrid Alphavirus Pseudovirus Technology.

Now with ready-to-use cells! No need to culture cells or CO2 incubators. Cells come pre-counted so just thaw and go.

Virongy’s Pseudoviral Neutralization Assay Kit is superior due to the implementation of our newly developed alpha pseudovirus. Alpha pseudoviruses are a newly developed hybrid virus-like particle (VLP) that encapsulates an alphavirus-derived RNA genome for rapid expression of reporter genes (luciferase or GFP) in target cells (Hetrick et al., 2022).

Different from commonly used S protein pseudotyped lenti- or vesicular stomatitis virus (VSV)-pseudoviruses, alpha pseudoviruses are assembled with all of the structural proteins of the target virus. These particles contain a reporter genome derived from an alphavirus-based vector for rapid (4 hours) and robust expression of reporter genes. Alpha pseudoviruses represent a major technological advancement in the development of pseudoviruses and serve as a platform for rapid and robust quantification of neutralization assays, viral mutants, and antiviral drugs (Dabbagh et al., 2021; He et al., 2021).

Virongy offers pre-assembled reporter pseudovirions and variants. We also help customers to perform antiviral drug screening and quantification of neutralizing antibodies. For more information, please contact us by email: info@virongy.com

Alpha pseudovirus major advances

  • A simple protocol that is easier than an ELISA-based method
  • Higher Accuracy than a traditional ELISA-based neutralization assay
  • Faster speed compared to other pseudoviruses– (Maximum reporter expression between 12-18 hours)
  • More robust reporter signal – Alpha pseudoviruses take advantage of an alphavirus vector’s rapid and robust gene expression capacity for reporter expression.
  • High fidelity in particle structure – Alpha pseudoviruses contain all of the virus structural proteins but no structural proteins from other viruses.
  • A strong correlation with the live virus in neutralizing antibody assays. 

Want to read more on the Alpha pseudovirus technology? Click Here



Virongy Biosciences의 모든 제품을 만나 보세요!


Products

Virus-Specific Tools

Psedoviruses

Kits and Reagents

Transduction Enhancers

Cell Lines


Services

Viral Neutralization Assay Services

Peptide Synthesis

Vector Synthesis


Virongy Biosciences - Exclusive Distributor in South Korea "Morebio" 한국 독점 대리점 "모아바이오"